electroCore,

electroCore, Earnings Growth

The Year-over-Year Earnings Growth of electroCore, (ECOR) as of Oct 17, 2026 is -17.50 %. In the previous year, Year-over-Year Earnings Growth was 36.89 % — a change of -147.44% (lower).

Earnings Growth

-17.50 %

YoY

-147.44%

Last updated:

Year-over-Year Earnings Growth of electroCore, is 2025 -17.50 % . Year-over-Year Earnings Growth of electroCore, was 2024 36.89 % . It decreases by -147.44% lower compared to the previous year.

The electroCore, Earnings Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Growth
Date
Earnings Growth
Jan 1, 2018
-55.96 USD
Jan 1, 2019
19.12 USD
Jan 1, 2020
47.92 USD
Jan 1, 2021
26.77 USD
Jan 1, 2022
-28.71 USD
Jan 1, 2023
15.02 USD
Jan 1, 2024
36.89 USD
Jan 1, 2025
-17.50 USD
The electroCore, Earnings Growth history
YEAREarnings GrowthYoY
-17.50 %-147.44%
36.89 %+145.66%
15.02 %-152.30%
-28.71 %-207.28%
26.77 %-44.15%
47.92 %+150.66%
19.12 %-134.17%
-55.96 %-56.09%
-127.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Year-over-Year Earnings Growth of electroCore, is -17.50 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Earnings Growth electroCore, since 2006 – with annual values, charts, and detailed analysis.

Earnings growth measures the percentage change in net income compared to the previous year. It reflects the company's improving or declining profitability.

To evaluate Year-over-Year Earnings Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Earnings Growth.

Year-over-Year Earnings Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Earnings Growth's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — electroCore,

All Key Metrics — electroCore,